A Pipeline in a Product

Revance’s initial focus is to develop and commercialize botulinum toxin type A (BoNTA) products for indications where topical application provides a meaningful advantage over injectable treatment. Our lead programs are in lateral canthal lines (crow’s feet wrinkles) and hyperhidrosis (excessive sweating). Revance is also pursuing additional dermatologic and therapeutic applications.